All Stories

  1. A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

    Article • Liver Cancer, June 2023, Karger Publishers

    Dr Yasuteru Kondo

  2. Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma

    Article • Cancers, March 2023, MDPI AG

    Dr Yasuteru Kondo

  3. Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

    Article • Drugs - Real World Outcomes, January 2023, Springer Science + Business Media

    Dr Yasuteru Kondo

  4. DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC

    Article • Scientific Reports, October 2022, Springer Science + Business Media

    Dr Yasuteru Kondo

  5. Clinical practice guidelines for autoimmune hepatitis

    Article • Hepatology Research, May 2022, Wiley

    Dr Yasuteru Kondo

  6. Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study

    Article • Journal of Clinical Medicine, March 2022, MDPI AG

    Dr Yasuteru Kondo

  7. Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment

    Article • Scientific Reports, March 2022, Springer Science + Business Media

    Dr Yasuteru Kondo

  8. DEB-TACE Combined With Hepatic Artery Infusion Chemotherapy Might Be an Affordable Treatment Option for Advanced Stage of HCC: Retrospective Study

    Article • March 2022, Research Square

    Dr Yasuteru Kondo

  9. Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis

    Article • Hepatology, August 2021, Wiley

    Dr Yasuteru Kondo

  10. Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma

    Article • Hepatology Research, June 2021, Wiley

    Dr Yasuteru Kondo

  11. Proposal of Stroop test cut‐off values as screening for neuropsychological impairments in cirrhosis: a Japanese multicenter study

    Article • Hepatology Research, February 2021, Wiley

    Dr Yasuteru Kondo

  12. Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals

    Article • Internal Medicine, February 2021, Japanese Society of Internal Medicine

    Dr Yasuteru Kondo

  13. Immune Checkpoint Inhibitor Can Reduce HCV-RNA without Liver Damage

    Article • Internal Medicine, September 2020, Japanese Society of Internal Medicine

    Dr Yasuteru Kondo

  14. Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B

    Article • Journal of Gastroenterology, July 2020, Springer Science + Business Media

    Dr Yasuteru Kondo

  15. Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway

    Article • Scientific Reports, January 2020, Springer Science + Business Media

    Dr Yasuteru Kondo

  16. The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection

    Article • Scientific Reports, September 2019, Springer Science + Business Media

    Dr Yasuteru Kondo

  17. Hepatitis C Virus infection could affect the pathogenesis of ischemic heart diseases in northern part of Japan

    Article • Hepatology Research, October 2018, Wiley

    Dr Yasuteru Kondo

  18. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers

    Article • International Journal of Obesity, May 2018, Springer Science + Business Media

    Dr Yasuteru Kondo

  19. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring

    Article • Internal Medicine, January 2018, Japanese Society of Internal Medicine

    Dr Yasuteru Kondo

  20. Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment

    Article • Scientific Reports, January 2017, Nature

    Dr Yasuteru Kondo

  21. Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2

    Article • Nature Communications, January 2017, Nature

    Dr Yasuteru Kondo

  22. Activation of the Hypoxia Inducible Factor 1 Alpha Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones

    Article • Gastroenterology, January 2017, Elsevier

    Dr Yasuteru Kondo

  23. Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment

    Article • World Journal of Gastroenterology, January 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Yasuteru Kondo

  24. PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment

    Article • Scientific Reports, December 2016, Nature

    Dr Yasuteru Kondo

  25. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma

    Article • Molecular Cancer, April 2016, Springer Science + Business Media

    Dr Yasuteru Kondo

  26. The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen

    Article • Journal of Viral Hepatitis, February 2016, Wiley

    Dr Yasuteru Kondo

  27. Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy

    Article • Clinical Journal of Gastroenterology, February 2016, Springer Science + Business Media

    Dr Yasuteru Kondo

  28. Shifting hepatitis B virus genotypes of acute hepatitis B patients in northeast Japan

    Article • Journal of Medical Virology, October 2015, Wiley

    Dr Yasuteru Kondo

  29. Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+Immune Cells

    Article • Journal of Virology, April 2015, ASM Journals

    Dr Yasuteru Kondo

  30. Significant biomarkers for the management of hepatocellular carcinoma

    Article • Clinical Journal of Gastroenterology, April 2015, Springer Science + Business Media

    Dr Yasuteru Kondo

  31. Significant Roles of Regulatory T Cells and Myeloid Derived Suppressor Cells in Hepatitis B Virus Persistent Infection and Hepatitis B Virus-Related HCCs

    Article • International Journal of Molecular Sciences, February 2015, MDPI AG

    Dr Yasuteru Kondo

  32. Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma

    Article • World Journal of Gastroenterology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Yasuteru Kondo

  33. Monitoring Serum Levels of Sorafenib and Its N-Oxide Is Essential for Long-Term Sorafenib Treatment of Patients with Hepatocellular Carcinoma

    Article • The Tohoku Journal of Experimental Medicine, January 2015, Tohoku University Medical Press

    Dr Yasuteru Kondo

  34. Radiation Therapy Is a Reasonable Option for Improving the Prognosis in Hepatocellular Carcinoma

    Article • The Tohoku Journal of Experimental Medicine, January 2015, Tohoku University Medical Press

    Dr Yasuteru Kondo

  35. HCV Infection Enhances Th17 Commitment, Which Could Affect the Pathogenesis of Autoimmune Diseases

    Article • PLoS ONE, June 2014, PLOS

    Dr Yasuteru Kondo

  36. Expression of EpCAM Increases in the Hepatitis B Related and the Treatment-Resistant Hepatocellular Carcinoma

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  37. A Quantitative HPLC-UV Method for Determination of Serum Sorafenib and Sorafenib N-Oxide and Its Application in Hepatocarcinoma Patients

    Article • The Tohoku Journal of Experimental Medicine, January 2014, Tohoku University Medical Press

    Dr Yasuteru Kondo

  38. Endoscopically proven case of rapid esophagogastric variceal progression and rupture as a result of portal hypertension with liver sarcoidosis

    Article • Digestive Endoscopy, December 2013, Wiley

    Dr Yasuteru Kondo

  39. Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis

    Article • ISRN Hepatology, December 2013, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  40. Plasma amino acids imbalance in cirrhotic patients disturbs the tricarboxylic acid cycle of dendritic cell

    Article • Scientific Reports, December 2013, Springer Science + Business Media

    Dr Yasuteru Kondo

  41. Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma

    Article • Hepatology Research, July 2013, Wiley

    Dr Yasuteru Kondo

  42. Sequential analysis of amino acid substitutions with hepatitis B virus in association with nucleoside/nucleotide analog treatment detected by deep sequencing

    Article • Hepatology Research, June 2013, Wiley

    Dr Yasuteru Kondo

  43. Three cases of adult-onset type II citrullinemia treated with different therapies: Efficacy of sodium pyruvate and low-carbohydrate diet

    Article • Hepatology Research, June 2013, Wiley

    Dr Yasuteru Kondo

  44. Distinct MicroRNAs Expression Profile in Primary Biliary Cirrhosis and Evaluation of miR 505-3p and miR197-3p as Novel Biomarkers

    Article • PLoS ONE, June 2013, PLOS

    Dr Yasuteru Kondo

  45. 1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial

    Article • PLoS ONE, May 2013, PLOS

    Dr Yasuteru Kondo

  46. Eradication of hepatitis C virus could improve immunological status and pyoderma gangrenosum-like lesions

    Article • Hepatology Research, April 2013, Wiley

    Dr Yasuteru Kondo

  47. Direct effects of hepatitis C virus on the lymphoid cells

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Yasuteru Kondo

  48. Supplementation of Branched-Chain Amino Acids Maintains the Serum Albumin Level in the Course of Hepatocellular Carcinoma Recurrence

    Article • The Tohoku Journal of Experimental Medicine, January 2013, Tohoku University Medical Press

    Dr Yasuteru Kondo

  49. PPARs and Liver Disease

    Article • PPAR Research, January 2013, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  50. Hepatitis B Surface Antigen Could Contribute to the Immunopathogenesis of Hepatitis B Virus Infection

    Article • ISRN Gastroenterology, January 2013, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  51. A case of sarcoidosis liver caused rupture of esophageal varices due to sudden portal hypertension

    Article • Kanzo, January 2013, Japan Society of Hepatology

    Dr Yasuteru Kondo

  52. Double Filtration Plasmapheresis Could Induce a Favorable Immune Response for Chronic Hepatitis C Therapy

    Article • Therapeutic Apheresis and Dialysis, October 2012, Wiley

    Dr Yasuteru Kondo

  53. Association between S21 substitution in the core protein of hepatitis B virus and fulminant hepatitis

    Article • Journal of Clinical Virology, October 2012, Elsevier

    Dr Yasuteru Kondo

  54. The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH)

    Article • Hepatology International, August 2012, Springer Science + Business Media

    Dr Yasuteru Kondo

  55. Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy

    Article • Journal of Gastroenterology, May 2012, Springer Science + Business Media

    Dr Yasuteru Kondo

  56. Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway

    Article • Virology, January 2012, Elsevier

    Dr Yasuteru Kondo

  57. The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis

    Article • ISRN Gastroenterology, January 2012, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  58. PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma

    Article • PPAR Research, January 2012, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  59. Biological Significance of HCV in Various Kinds of Lymphoid Cells

    Article • International Journal of Microbiology, January 2012, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  60. Use of Illumina Deep Sequencing Technology To Differentiate Hepatitis C Virus Variants

    Article • Journal of Clinical Microbiology, December 2011, ASM Journals

    Dr Yasuteru Kondo

  61. Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients

    Article • Hepatology Research, September 2011, Wiley

    Dr Yasuteru Kondo

  62. Enhanced Replication of Hepatitis B Virus With Frameshift in the Precore Region Found in Fulminant Hepatitis Patients

    Article • The Journal of Infectious Diseases, August 2011, Oxford University Press (OUP)

    Dr Yasuteru Kondo

  63. Plasma L-Cystine/L-Glutamate Imbalance Increases Tumor Necrosis Factor-Alpha from CD14+ Circulating Monocytes in Patients with Advanced Cirrhosis

    Article • PLoS ONE, August 2011, PLOS

    Dr Yasuteru Kondo

  64. Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern

    Article • Journal of Viral Hepatitis, February 2011, Wiley

    Dr Yasuteru Kondo

  65. Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection

    Article • Gastroenterology Research and Practice, January 2011, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  66. The Nutritional Index ‘CONUT’ Is Useful for Predicting Long-Term Prognosis of Patients with End-Stage Liver Diseases

    Article • The Tohoku Journal of Experimental Medicine, January 2011, Tohoku University Medical Press

    Dr Yasuteru Kondo

  67. Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT

    Article • Hepatitis Research and Treatment, January 2011, Hindawi Publishing Corporation

    Dr Yasuteru Kondo

  68. Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-γ secretion activity

    Article • Journal of Gastroenterology, August 2010, Springer Science + Business Media

    Dr Yasuteru Kondo

  69. Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines

    Article • Cancer Science, August 2010, Wiley

    Dr Yasuteru Kondo

  70. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice

    Article • Journal of Hepatology, August 2010, Elsevier

    Dr Yasuteru Kondo

  71. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein

    Article • Biochemical and Biophysical Research Communications, August 2010, Elsevier

    Dr Yasuteru Kondo

  72. Hepatitis B Virus Replication Could Enhance Regulatory T Cell Activity by Producing Soluble Heat Shock Protein 60 From Hepatocytes

    Article • The Journal of Infectious Diseases, July 2010, Oxford University Press (OUP)

    Dr Yasuteru Kondo

  73. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-γ ligand, rosiglitazone

    Article • Biochemical and Biophysical Research Communications, May 2010, Elsevier

    Dr Yasuteru Kondo

  74. Enhanced intracellular retention of a hepatitis B virus strain associated with fulminant hepatitis

    Article • Virology, December 2009, Elsevier

    Dr Yasuteru Kondo

  75. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis

    Article • Hepatology, August 2009, Wiley

    Dr Yasuteru Kondo

  76. A novel third generation bisphosphonate, minodronate (YM529), prevented proliferation and migration of hepatocellular carcinoma cells through inhibition of mevalonate pathway

    Article • Hepatology Research, May 2009, Wiley

    Dr Yasuteru Kondo

  77. Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies

    Article • Clinical Journal of Gastroenterology, March 2009, Springer Science + Business Media

    Dr Yasuteru Kondo

  78. Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan

    Article • Journal of Gastroenterology, March 2009, Springer Science + Business Media

    Dr Yasuteru Kondo

  79. Hepatitis C Virus Infection of T Cells Inhibits Proliferation and Enhances Fas-Mediated Apoptosis by Down-Regulating the Expression of CD44 Splicing Variant 6

    Article • The Journal of Infectious Diseases, March 2009, Oxford University Press (OUP)

    Dr Yasuteru Kondo

  80. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases

    Article • Journal of Gastroenterology, September 2008, Springer Science + Business Media

    Dr Yasuteru Kondo

  81. A case of HIV co-infected with hepatitis B virus precorecore deletion mutant treated by entecavir

    Article • Hepatology Research, August 2008, Wiley

    Dr Yasuteru Kondo

  82. Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein

    Article • Journal of Virology, April 2008, ASM Journals

    Dr Yasuteru Kondo

  83. Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan

    Article • World Journal of Gastroenterology, January 2008, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Yasuteru Kondo

  84. Hepatitis C virus infects T cells and affects interferon-γ signaling in T cell lines

    Article • Virology, April 2007, Elsevier

    Dr Yasuteru Kondo

  85. Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24–positive chronic hepatitis C patients

    Article • Journal of Gastroenterology, September 2006, Springer Science + Business Media

    Dr Yasuteru Kondo

  86. Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B

    Article • World Journal of Gastroenterology, January 2006, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Yasuteru Kondo

  87. Interferon-gamma is produced by CD8+ T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss

    Article • Clinical & Experimental Immunology, July 2005, Wiley

    Dr Yasuteru Kondo

  88. Living Related Liver Transplantation for Acute Fulminant Hepatitis B: Experience from Two Possible Hyper-Acute Cases

    Article • The Tohoku Journal of Experimental Medicine, January 2005, Tohoku University Medical Press

    Dr Yasuteru Kondo

  89. Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8+ T lymphocytes in fulminant hepatitis B

    Article • December 2004, Wiley

    Dr Yasuteru Kondo

  90. Lack of common mutation in the alfa-subunit of the mitochondrial trifunctional protein and the polymorphism of CYP2E1 in three Japanese women with acute fatty liver of pregnancy/HELLP syndrome

    Article • Hepatology Research, December 2004, Elsevier

    Dr Yasuteru Kondo

  91. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity

    Article • Journal of Medical Virology, January 2004, Wiley

    Dr Yasuteru Kondo

  92. Distribution of the HLA Class I Allele in Chronic Hepatitis C and its Association with Serum ALT Level in Chronic Hepatitis C

    Article • The Tohoku Journal of Experimental Medicine, January 2003, Tohoku University Medical Press

    Dr Yasuteru Kondo